Skip to main content
. Author manuscript; available in PMC: 2021 Aug 4.
Published in final edited form as: Acta Neuropathol. 2020 Mar 13;139(6):1105–1107. doi: 10.1007/s00401-020-02141-x

Table 2.

VAFs detected in Case #2′s glioma using a NGS panel

Gene Transcript Exon Genomic cDNA Variant classification Variant frequency
ATRX NM_000489.3 Ex9 chrX:g.76939909CA>C c.838delT Pathogenic 0.66
IDH1 NM_005896.3 Ex4 chr2:g.209113112C>T c.395G>A Pathogenic 0.32
TP53 NM_000546.5 Ex5 chr17:g.7578542G>A c.388C>T Pathogenic 0.77

Notice the doubling of the ATRX VAF for this male patient compared to IDH1, present in an autosome. TP53 presented with loss-of-heterozygosity (LOH), which is in agreement with the observed mutation frequency being approximately double of IDH1